Syndax Pharmaceuticals (SNDX) Asset Utilization Ratio (2016 - 2026)

Syndax Pharmaceuticals' Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.43 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 577.44% year-over-year to 0.43; the TTM figure through Mar 2026 stood at 0.43 (up 577.44% YoY), while the FY2025 annual figure was 0.27, up 676.09% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.43, up from 0.32 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.43 in Q1 2026, with the low at 0.01 in Q2 2024.
• The 4-year median for Asset Utilization Ratio is 0.19 (2025), against an average of 0.19.
• The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio tumbled 97.81% in 2024, then surged 1742.04% in 2025.
• Syndax Pharmaceuticals' Asset Utilization Ratio stood at 0.25 in 2023, then tumbled by 83.54% to 0.04 in 2024, then jumped by 675.47% to 0.32 in 2025, then surged by 35.91% to 0.43 in 2026.
• Business Quant data shows SNDX's Asset Utilization Ratio at 0.43 in Q1 2026, 0.32 in Q4 2025, and 0.19 in Q3 2025.